跳至主要内容
临床试验/NCT05326373
NCT05326373已完成不适用

A Pilot Study to Evaluate Gingivitis Using Traditional and Molecular Methods

Procter and Gamble1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年4月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
MGI

研究概览

简要总结

8-week study using stannous fluoride toothpaste on subjects with gingivitis ("unhealthy") and without gingivitis ("healthy"). Gingivitis index will be performed at BL, Week 4 and Week 8. A number of biological samples will be collected at each timepoint.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be 18 years of age or older;
  • Provide written informed consent and receive a signed copy of consent;
  • Agree to delay any elective dentistry, including dental prophylaxis, and to report any non-study dentistry received during the course of this study;
  • Agree not to participate in any other oral care studies for the duration of this study;
  • Agree to refrain from any form of non-specified oral hygiene during the treatment periods, including but not limited to the use of products such as floss or whitening products;
  • Agree to return for all scheduled visits and follow study procedures;
  • Have at least 16 natural teeth;
  • Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study.
  • For Unhealthy Group:
  • Have at least 20 bleeding sites (sites with a score of 1 or 2 on the Screening GBI exam); and
  • Have a minimum of 3 sampling sites with bleeding and pocket depth >/=3mm but not deeper than 4mm at the Screening visit.
  • For Healthy Group:
  • Have a maximum of 3 bleeding sites (sites with a score of 1 or 2 on the Screening GBI exam); and
  • No pockets deeper than 2mm.

排除标准

  • Self-reported pregnancy or the intent to become pregnant anytime during the course of the study;
  • Inability to comply with study procedures;
  • Rampant caries, open or untreated caries, or advanced periodontitis requiring prompt treatment;
  • Severe periodontal disease, including but not limited to purulent exudate, generalized mobility, and/or severe recession;
  • Fixed orthodontic appliances or attachments for aligner treatment;
  • Having had a dental prophylaxis within 2 weeks of plaque sampling visits;
  • Having taken antibiotics or used anti-gingivitis/anti-bacterial oral care products such as chlorhexidine or Listerine within 2 weeks of plaque sampling visits;
  • Needing an antibiotic prophylaxis prior to dental visits;
  • Presenting with any disease or condition(s) that could be expected to interfere with examination procedures or the subject's safe completion of the study; or
  • Having any condition or disease, as determined by the Investigator/Designee which could be expected to interfere with examination procedures or with the subject's safe completion of the study.

研究组 & 干预措施

Healthy Group

Active Comparator

Subjects without gingivitis (</= 3 bleeding sites) will use stannous fluoride toothpaste

干预措施: Stannous fluoride (Drug)

Unhealthy Group

Active Comparator

Subjects with gingivitis (>/= bleeding 20 sites) will use stannous fluoride toothpaste

干预措施: Stannous fluoride (Drug)

结局指标

主要结局

MGI

时间窗: 8 weeks

Modified Gingival Index- validated assessment of gingival health looking at inflammation based on 4-point range 0 (normal gingiva) to 4 (severe inflammation).

GBI

时间窗: 8 weeks

Gingival Bleeding Index- validated assessment of gingival health looking at bleeding based on 2-point range 0 (Absence of bleeding) to 2 (Immediate bleeding)

次要结局

未报告次要终点

研究者

发起方
Procter and Gamble
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验